| Course | NRS 455 Pathophysiology |
|---|---|
| Topic | Topic 8 |
| Paper type | Mechanism-based treatment paper |
| Length | About 1,050 words, 4 pages |
| Format | APA 7 student paper |
| School | Grand Canyon University (GCU) |
| Program | RN to BSN |
| Updated | October 2026 |
Free sample paper for NRS 455 Topic 8
Acute Angle-Closure Glaucoma From Mechanism to Treatment: Placing Each Therapy on the Step It Interrupts
[Author Name]
College of Nursing and Health Care Professions, Grand Canyon University
NRS-455: Pathophysiology
Topic 8 Assignment
[Instructor Name]
December 7, 2026
The organization, setting and figures below are a composite written as a model document. No real employer, client, colleague or patient is described.
Acute Angle-Closure Glaucoma From Mechanism to Treatment: Placing Each Therapy on the Step It Interrupts
The Patient
Mrs. H. T., 67, arrives at the emergency department at 2200 with severe pain in her left eye and forehead, blurred vision with colored halos around lights, nausea and two episodes of vomiting. The pain began about two hours earlier while she was watching a movie in a dark theater. She is farsighted and wears reading glasses. On examination her left eye is red, the cornea looks hazy, the pupil is fixed in mid-dilation, and the eye feels firm through the closed lid. Visual acuity is counting fingers at 3 feet in the left eye and 20/30 in the right. Intraocular pressure measured by tonometry is 58 mm Hg in the left eye and 16 in the right, against a usual range of about 10 to 21. She has mild asthma, uses an inhaler about once a month, and has hypertension treated with amlodipine.
The Chain, From Initiating Event to Sign
Step 1, aqueous production. The ciliary body behind the iris continuously secretes aqueous humor into the posterior chamber. Normally the fluid flows forward through the pupil into the anterior chamber and drains out through the trabecular meshwork in the angle, where the iris meets the cornea. Production and outflow are balanced, keeping pressure normal (Weinreb et al., 2014).
Step 2, pupillary block. In an eye like Mrs. T.'s, which is short and farsighted with a crowded anterior segment, the lens sits close to the back of the iris. When the pupil dilates to a mid position, as it does in a dark room, the contact between iris and lens is greatest, and aqueous can no longer pass freely through the pupil (Sun et al., 2017).
Step 3, iris bombe. Pressure builds behind the iris, pushing its thin, peripheral part forward like a sail. The bowed iris presses against the trabecular meshwork and closes the angle.
Step 4, pressure rise. With outflow blocked and production continuing, intraocular pressure climbs rapidly, to 58 in her case.
Step 5, the signs. High pressure forces fluid into the cornea, making it cloudy, which scatters light and produces halos. Pressure on the iris sphincter muscle damages it, leaving the pupil fixed. Stretching of ocular tissues causes intense pain, and signals through the vagus nerve cause nausea and vomiting. If pressure stays high, blood flow to the optic nerve head is reduced and nerve fibers die, causing permanent vision loss. Every therapy that follows acts on one of these five steps, and the paper introduces each at that step rather than in a list.
Therapies Placed on the Steps They Interrupt
At Step 1, therapies reduce how much aqueous is made. A topical beta-adrenergic blocker such as timolol blocks beta receptors in the ciliary epithelium and lowers aqueous production. An alpha-2 agonist such as apraclonidine also reduces production. A carbonic anhydrase inhibitor such as acetazolamide, given intravenously or by mouth, blocks the enzyme the ciliary epithelium uses to form bicarbonate, and because water follows bicarbonate into the aqueous, secretion falls (Weinreb et al., 2014).
At Step 4, a hyperosmotic agent lowers pressure directly. Intravenous mannitol raises the osmolality of the blood, drawing water out of the vitreous body into the circulation, which shrinks the volume behind the lens and lowers intraocular pressure within an hour.
At Step 3, pilocarpine, a cholinergic agonist, contracts the iris sphincter, constricting the pupil and pulling the peripheral iris away from the angle. It is usually given once pressure has begun to fall, because an iris muscle starved of blood by very high pressure may not respond.
At Step 2, the definitive treatment bypasses the block. A laser peripheral iridotomy creates a small hole in the peripheral iris, giving aqueous a new path from the posterior to the anterior chamber, so the pressure behind the iris equalizes and the iris falls back from the angle (Sun et al., 2017). Because the other eye shares the same anatomy, a preventive iridotomy is usually recommended for it as well.
The order matters as much as the choice. Drugs that reduce production and draw fluid out act first, within the first hour, because the optic nerve is losing blood flow while the pressure stays high; the laser comes once the cornea has cleared enough to see through, often the next day.
Adverse Effects as the Same Mechanism Elsewhere
Each drug's side effects are its mechanism acting somewhere other than the eye. Timolol drops are absorbed into the circulation through the nasal mucosa, where they block beta receptors in the airways and heart; in Mrs. T., who has asthma, that can cause bronchospasm, and it can also slow the heart rate. For that reason a beta-blocker may be avoided or used with caution in her, with the nurse listening for wheeze and watching her heart rate. Acetazolamide blocks carbonic anhydrase in the kidney as well as the eye, so bicarbonate is lost in the urine, causing a mild metabolic acidosis, tingling of the fingers and potassium loss. Mannitol pulls water out of all tissues into the blood, expanding blood volume and causing a large diuresis, which can precipitate heart failure in a patient with limited cardiac reserve and cause dehydration afterward. Pilocarpine acts on muscarinic receptors elsewhere and can cause brow ache, sweating and, with systemic absorption, nausea and slow heart rate (Rogers, 2023).
Monitoring That Follows the Chain
Each parameter the nurse watches reports on a step. Intraocular pressure, rechecked every 30 to 60 minutes after treatment begins, reports on Steps 1 through 4 together and shows whether the pressure is falling. Pupil size and reaction report on Step 3, whether pilocarpine is pulling the iris from the angle. Visual acuity and pain report on Step 5, the damage the pressure is doing, and improving acuity is the most meaningful sign for the patient. Monitoring for drug effects follows their mechanisms elsewhere: breath sounds and oxygen saturation if a beta-blocker is given, heart rate and blood pressure, serum potassium and bicarbonate after acetazolamide, and urine output, lung sounds and blood pressure after mannitol. Nausea and vomiting are treated and reassessed, because vomiting raises intraocular pressure further. After iridotomy, the pressure check the next day confirms that the new path for aqueous is working.
References
Rogers, J. L. (Ed.). (2023). McCance & Huether's pathophysiology: The biologic basis for disease in adults and children (9th ed.). Elsevier.
Sun, X., Dai, Y., Chen, Y., Yu, D.-Y., Cringle, S. J., Chen, J., Kong, X., Wang, X., & Jiang, C. (2017). Primary angle closure glaucoma: What we know and what we don't know. Progress in Retinal and Eye Research, 57, 26-45. https://doi.org/10.1016/j.preteyeres.2016.12.003
Weinreb, R. N., Aung, T., & Medeiros, F. A. (2014). The pathophysiology and treatment of glaucoma: A review. JAMA, 311(18), 1901-1911. https://doi.org/10.1001/jama.2014.3192
What the NRS 455 Topic 8 instructions ask for
Topic 8 in NRS-455 asks students to connect a disease mechanism to its treatment. Strong papers lay out the chain from initiating event to sign, step by step, then place each therapy on the step it interrupts and explain how. Students should explain adverse effects as the same mechanism acting elsewhere in the body, connect them to the patient's history, such as asthma with a beta blocker, and describe monitoring that reports on specific steps of the chain. Enough pharmacology to explain each therapy's action is needed, but the paper is a mechanism analysis rather than a care plan, and a case from earlier in the course can often be reused.
Inside the NRS 455 Topic 8 example
The finished paper reads as one continuous argument rather than as a case followed by a treatment list. A composite patient opens it with the presenting problem and the findings that matter. The mechanism section rebuilds the chain from the initiating event to the sign, at the depth the earlier topics established. Then the paper turns, and each therapy is introduced at the point in that chain where it acts: a drug class named by what it inhibits, an intervention named by the pressure or the volume it changes. Expected effects are stated as reversals of specific steps, and adverse effects appear as the same drug acting on a step somewhere else. Monitoring parameters follow from the mechanism rather than from a protocol.
Where the marks sit in the NRS 455 Topic 8 rubric
Faculty reward each therapy placed on the step it interrupts. An Excellent paper traces aqueous production, pupillary block, angle closure and rising pressure, citing Weinreb and colleagues and Sun and colleagues. Credit goes to placing timolol and acetazolamide at production and pilocarpine at the angle. The rubric values explaining side effects as the same mechanism elsewhere, such as timolol causing bronchospasm in Mrs. T., who has asthma. Strong papers time intraocular pressure checks every 30 to 60 minutes. Top marks go to monitoring tied to specific steps.
Common NRS 455 Topic 8 mistakes, and how to avoid them
The characteristic failure here is a paper in two halves that never meet. A careful mechanism followed by a treatment list copied from a drug reference earns something for each part and nothing for the connection, which is the criterion this topic exists for. Drugs described by indication rather than by action are the visible symptom, because an indication names a disease and not a step. Adverse effects presented as a list cost the same points, since this course expects them as the drug acting elsewhere. Monitoring parameters lifted from a protocol without a reason are the third leak. Papers that promote management above mechanism start reading like a different course. The strongest papers name a step that no available treatment reaches.
Get an NRS-455 Topic 8 example written to your instructions
Send the assignment instructions and the rubric from your NRS 455 classroom, plus the case or condition your section is working from. We write a custom example to those criteria, with the chain established first and each therapy placed on the step it interrupts, and return it in 24 to 48 hours. The first custom sample is free.
More NRS 455 papers and RN to BSN samples
- NRS 455 Topic 1: Mechanism Write-up
- NRS 455 Topic 2: DQ Response
- NRS 455 Topic 3: Lab Value Interpretation
- NRS 455 Topic 4: Heart Failure Pathophysiology Case Analysis
- NRS 455 Topic 5: Concept Map
- NRS 455 Topic 6: Case Study Analysis
- NRS 455 Topic 7: Patient Teaching Plan
- NRS 460 Topic 8: Comprehensive Management Plan
- NRS 450 Topic 8: Data Reporting Proposal
- NRS 465 Topic 8: Project Presentation
- NRS 445 Topic 8: Synthesis and Dissemination Plan
NRS 455 Topic 8 questions, answered
Is this topic asking for a care plan?
Not in the sense the management courses mean. The deliverable stays a pathophysiology argument that happens to reach treatment, so the reasoning runs from process to intervention rather than from problem to nursing action. If your instructions do call for a care plan format, keep every entry justified by the mechanism, because that is what this course is reading for.
How much pharmacology should the paper include?
Enough to explain the action, not enough to become a drug guide. Class, target and effect on the step in question are usually the right depth, with doses left out unless your instructions ask for them. Depth belongs to the two or three therapies acting on the chain you built rather than to every medication the patient might receive.
Can I reuse the case from earlier in the course?
Often yes, and it usually improves the paper, since the mechanism already has a documented starting point. Check your instructions for any rule against reusing material, then write it again rather than pasting, because similarity reports through LopesWrite include your own earlier submissions in many classrooms. The argument here reaches further than the earlier one did.
Where can I find a free NRS 455 Topic 8 sample paper?
The treatment paper for NRS 455 Topic 8 for NRS 455 Topic 8 covers the patient, the chain from initiating event to sign, therapies placed on the steps they interrupt, adverse effects as the same mechanism elsewhere and monitoring that follows the chain. Send your NRS 455 Topic 8 prompt and a paper follows free.
Is NRS 455 Topic 8 asking for a care plan?
Not in the usual sense. It asks how each treatment interrupts the disease chain and what to monitor at each step, which is pathophysiology applied rather than a nursing care plan.